Clinical trials
Available Expanded access trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
252 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 3 |
| 2016 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Available | 252 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 14 |
| Regeneron Pharmaceuticals | 7 |
| AbbVie | 5 |
| Bristol-Myers Squibb | 4 |
| National Taiwan University Hospital | 4 |
| Pfizer | 4 |
| Takeda | 4 |
| Amicus Therapeutics | 3 |
| Eli Lilly and Company | 3 |
| GlaxoSmithKline | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 12 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Glioblastoma | 6 |
| Multiple Myeloma | 6 |
| Neuroblastoma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Prostatic Neoplasms | 6 |
| Recurrence | 6 |
| Sarcoma | 6 |
| Breast Neoplasms | 5 |
Trials
Showing 1 to 25 of 252. Each trial links to its page on Pharma Observatory.
152 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.